We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$65.7B
AUM Growth
+$7.59B
Cap. Flow
-$1.34B
Cap. Flow %
-2.05%
Top 10 Hldgs %
12.37%
Holding
7,215
New
735
Increased
2,740
Reduced
3,074
Closed
505

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$245M
2
KEY icon
KeyCorp
KEY
+$199M
3
RTX icon
RTX Corp
RTX
+$183M
4
EMC
EMC CORPORATION
EMC
+$170M
5
RL icon
Ralph Lauren
RL
+$167M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$245M
2
USB icon
US Bancorp
USB
+$216M
3
AAPL icon
Apple
AAPL
+$207M
4
V icon
Visa
V
+$188M
5
BAC icon
Bank of America
BAC
+$177M

Sector Composition

Rank Sector Weight
1 Financials 9.51%
2 Consumer Discretionary 7.62%
3 Energy 7.06%
4 Technology 6.57%
5 Industrials 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVLT
5951
PUT
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$28K ﹤0.01%
+1,110
New +$40.3K
BALT
5952
CALL
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
$28K ﹤0.01%
+5,800
New +$25.3K
RNA
5953
PUT
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$28K ﹤0.01%
+4,300
New +$101K
VSB
5954
DELISTED
VANTAGESOUTH BANCHARES, INC
VSB
$28K ﹤0.01%
+5,195
New +$26.8K
MCP.PRA
5955
DELISTED
MOLYCORP, INC PFD CONV SER A
MCP.PRA
$28K ﹤0.01%
1,363
+1,240
+1,008% +$27.8K
BHE icon
5956
CALL
Benchmark Electronics
BHE
$2.92B
$27K ﹤0.01%
1,200
-1,600
-57% -$35.4K
EME icon
5957
CALL
Emcor
EME
$36B
$27K ﹤0.01%
700
-4,200
-86% -$170K
MASI
5958
PUT
DELISTED
Masimo
MASI
$27K ﹤0.01%
1,000
-1,800
-64% -$44.4K
MKSI icon
5959
CALL
MKS Inc
MKSI
$19.9B
$27K ﹤0.01%
1,000
-200
-17% -$5.34K
TTMI icon
5960
CALL
TTM Technologies
TTMI
$13.8B
$27K ﹤0.01%
2,800
-1,300
-32% -$12.4K
ENZ
5961
PUT
DELISTED
Enzo Biochem, Inc.
ENZ
$27K ﹤0.01%
10,800
+100
+0.9% +$237
ENLC
5962
PUT
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$27K ﹤0.01%
1,300
-1,600
-55% -$32.4K
GMO
5963
DELISTED
General Moly, Inc.
GMO
$27K ﹤0.01%
16,134
-82,468
-84% -$149K
BMS
5964
CALL
DELISTED
Bemis
BMS
$27K ﹤0.01%
700
-3,400
-83% -$138K
FNFG
5965
PUT
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
$27K ﹤0.01%
2,600
+100
+4% +$1.04K
BALT
5966
PUT
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
$27K ﹤0.01%
+5,600
New +$24.4K
BPZ
5967
PUT
DELISTED
BPZ RESOURCES INC COM STK
BPZ
$27K ﹤0.01%
13,600
-32,400
-70% -$72.8K
CADX
5968
PUT
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
$27K ﹤0.01%
4,200
-3,900
-48% -$24.8K
WRES
5969
PUT
DELISTED
WARREN RESOURCES INC
WRES
$27K ﹤0.01%
9,300
-2,900
-24% -$8.42K
AMSC icon
5970
CALL
American Superconductor
AMSC
$1.56B
$26K ﹤0.01%
1,100
+60
+6% +$1.52K
ANIK icon
5971
PUT
Anika Therapeutics
ANIK
$284M
$26K ﹤0.01%
+1,100
New +$24.7K
AXS icon
5972
CALL
AXIS Capital
AXS
$7.35B
$26K ﹤0.01%
600
BLMN icon
5973
PUT
Bloomin' Brands
BLMN
$952M
$26K ﹤0.01%
1,100
-1,700
-61% -$40.7K
CENX icon
5974
Century Aluminum
CENX
$5.18B
$26K ﹤0.01%
3,209
+1,958
+157% +$17.3K
DVAX
5975
DELISTED
Dynavax Technologies
DVAX
$26K ﹤0.01%
2,176
+385
+21% +$4.84K

Similar funds

Citadel Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Citadel Advisors's Q3 2013 filing shows 735 new, 2,740 increased, 3,074 reduced and 505 closed positions. Its largest new stake was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M. The largest sale was Pfizer, an estimated $245M.

By sector, the portfolio is most concentrated in Financials at 9.5% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Energy.

  • Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
  • Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
  • Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
  • Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
  • Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
  • Citadel Advisors opened 735 new positions and closed 505 in Q3 2013.
  • Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.

Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.